VIVS VivoSim Labs Company Net Income

Official company branding of Organovo Holdings, Inc. (VIVS)

Is it worth investing in the VivoSim Labs Inc (VIVS) 3D bioprinting ecosystem that streamlines pharmaceutical testing? This chart in the GURU.Markets terminal shows the company's financial performance history stabilizing at -0.01. The business's leadership is based on the NovoGen platform, which creates living organs for Big Pharma. Operational stability is ensured by a diversified network of laboratories and strict control over the express logistics of biomaterials.

VIVS VivoSim Labs Inc Net Income (04/25/2025 - 10/31/2026)

Financial and market metric breakdowns for Organovo Holdings Inc. (VIVS)

- stock quotes and analyst forecast:
Share Price Organovo Holdings|VIVS - Price Target Chart
- market capitalization data:
Market Value VivoSim Labs|VIVS - Total Company Value
- balance sheet equity data:
Net Assets per Share Organovo|VIVS - Company Net Assets|Market Cap to Book Value Multiple organovo.com|VIVS - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient VivoSim Labs Inc|VIVS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio VivoSim Labs|VIVS - Company Total Debt|Debt to Net Assets Ratio VivoSim Labs|VIVS - Company Long-Term Debt|Company Current Liabilities Organovo|Immediate Liquidity organovo.com
- earnings and multiples data:
VIVS - Net Profit
Summary company analysis:organovo.com (VIVS)
Mass-produced product of VivoSim Labs Inc

Investors are assessing the resilience of VivoSim Labs Inc (VIVS) through daily net income volume, which reflects real business efficiency given current market conditions. By analyzing the company's annual financial results, one can determine how successfully its proprietary 3D bioprinting technologies are being monetized under strict FDA regulatory oversight, where steady profit growth confirms the fundamental value of the assets.

Main competitors

Company Profit ABT|Company Net Income Thermo Fisher Scientific|Company Net Income gehealthcare.com GEHC|Company Net Income Mettler Toledo (MTD)|Net Financial Result Waters Corp|Techne Corporation - Net Income|Profit After Payment of Taxes BRKR (Bruker BioSpin)|Azenta, Inc. - Net Profit|Net Financial Result vareximaging.com VREX|SMLR: Net Profit|Net Income Butterfly Network Inc|Net Income MLAB|QSI: Final Profit|Company Net Income Nano-X Imaging Ltd. (NNOX)|Net Income quanterix.com QTRX|Net Profit MASS (908 Devices)|CapsoVision, Inc. (CV) - Company Net Income|MaxCyte, Inc - Net Profit|RPID (Rapid Micro Biosystems) - Company Profit|SEER: Net Profit|HYPR - Net Financial Result|FONR (FONAR) - Net Profit|Net Income Daxor Corp. (DXR)|Net Profit MDAI|Net Profit Aclarion Corporation (ACON)|Company Net Income Akoya Biosciences, Inc. AKYA|thermogenesis.com - Company Net Income|TLIS: Net Income|Final Profit TTOO (T2 Biosystems Inc.)